Supplementary Data from Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma
Authors:
- Leo I. GordonLGLeo I. Gordon
- Jason B. KaplanJKJason B. Kaplan
- Rakesh PopatRPRakesh Popat
- Howard A. BurrisHBHoward A. Burris
- Silvia FerrariSFSilvia Ferrari
- Sumit MadanSMSumit Madan
- Manish R. PatelMPManish R. Patel
- Giuseppe GrittiGGGiuseppe Gritti
- Dima El-SharkawiDEDima El-Sharkawi
- Ian ChauICIan Chau
- John A. RadfordJRJohn A. Radford
- Jaime Pérez de OteyzaJOJaime Pérez de Oteyza
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)